Literature DB >> 17462532

The chemistry and biology of nitroxide compounds.

Benjamin P Soule1, Fuminori Hyodo, Ken-Ichiro Matsumoto, Nicole L Simone, John A Cook, Murali C Krishna, James B Mitchell.   

Abstract

Cyclic nitroxides are a diverse group range of stable free radicals that have unique antioxidant properties. Because of their ability to interact with free radicals, they have been used for many years as biophysical tools. During the past 15-20 years, however, many interesting biochemical interactions have been discovered and harnessed for therapeutic applications. Biologically relevant effects of nitroxides have been described, including their ability to degrade superoxide and peroxide, inhibit Fenton reactions, and undergo radical-radical recombination. Cellular studies defined the activity of nitroxides in vitro. By modifying oxidative stress and altering the redox status of tissues, nitroxides have been found to interact with and alter many metabolic processes. These interactions can be exploited for therapeutic and research use, including protection against ionizing radiation, as probes in functional magnetic resonance imaging, cancer prevention and treatment, control of hypertension and weight, and protection from damage resulting from ischemia/reperfusion injury. Although much remains to be done, many applications have been well studied and some are currently being tested in clinical trials. The therapeutic and research uses of nitroxide compounds are reviewed here with a focus on the progress from initial development to modern trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462532      PMCID: PMC1991293          DOI: 10.1016/j.freeradbiomed.2007.02.030

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  95 in total

Review 1.  Pathophysiology of Parkinson's disease.

Authors:  A M Bonnet; J L Houeto
Journal:  Biomed Pharmacother       Date:  1999-04       Impact factor: 6.529

2.  Cardiac reperfusion damage prevented by a nitroxide free radical.

Authors:  D Gelvan; P Saltman; S R Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 3.  Principles of the metabolism of nitroxides and their implications for spin trapping.

Authors:  H M Swartz
Journal:  Free Radic Res Commun       Date:  1990

4.  Caloric restriction and aging.

Authors:  R Weindruch
Journal:  Sci Am       Date:  1996-01       Impact factor: 2.142

5.  Nitroxide-doped liposomes containing entrapped oxidant: an approach to the "reduction problem" of nitroxides as MRI contrast agents.

Authors:  J F Keana; S Pou
Journal:  Physiol Chem Phys Med NMR       Date:  1985

6.  Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.

Authors:  P K Chatterjee; S Cuzzocrea; P A Brown; K Zacharowski; K N Stewart; H Mota-Filipe; C Thiemermann
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

7.  Cellular sites of H2O2-induced damage and their protection by nitroxides.

Authors:  A M Samuni; W DeGraff; M C Krishna; J B Mitchell
Journal:  Biochim Biophys Acta       Date:  2001-02-16

8.  Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.

Authors:  R Rak; D L Chao; R M Pluta; J B Mitchell; E H Oldfield; J C Watson
Journal:  J Neurosurg       Date:  2000-04       Impact factor: 5.115

9.  Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

Authors:  J P Spencer; P Jenner; S E Daniel; A J Lees; D C Marsden; B Halliwell
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

10.  Decline in the expression of copper/zinc superoxide dismutase in the kidney of rats with endotoxic shock: effects of the superoxide anion radical scavenger, tempol, on organ injury.

Authors:  M Leach; S Frank; A Olbrich; J Pfeilschifter; C Thiemermann
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

View more
  119 in total

Review 1.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

2.  Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats.

Authors:  Nelson Escobales; Rebeca E Nuñez; Sehwan Jang; Rebecca Parodi-Rullan; Sylvette Ayala-Peña; Joshua R Sacher; Erin M Skoda; Peter Wipf; Walter Frontera; Sabzali Javadov
Journal:  J Mol Cell Cardiol       Date:  2014-10-23       Impact factor: 5.000

3.  Design and synthesis of novel spin-labeled camptothecin derivatives as potent cytotoxic agents.

Authors:  Xiao-Bo Zhao; Dan Wu; Mei-Juan Wang; Masuo Goto; Susan L Morris-Natschke; Ying-Qian Liu; Xiao-Bing Wu; Zi-Long Song; Gao-Xiang Zhu; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

4.  Protective effect of an antithyroid compound against γ-radiation-induced damage in human colon cancer cells.

Authors:  Marina Perona; Maria A Dagrosa; Romina Pagotto; Mariana Casal; Omar Pignataro; Mario A Pisarev; Guillermo J Juvenal
Journal:  Radiat Environ Biophys       Date:  2014-05-09       Impact factor: 1.925

Review 5.  Altering the response to radiation: sensitizers and protectors.

Authors:  Deborah E Citrin; James B Mitchell
Journal:  Semin Oncol       Date:  2014-10-07       Impact factor: 4.929

6.  The mitochondria-targeted nitroxide JP4-039 augments potentially lethal irradiation damage repair.

Authors:  Malolan S Rajagopalan; Kanika Gupta; Michael W Epperly; Darcy Franicola; Xichen Zhang; Hong Wang; Hong Zhao; Vladimir A Tyurin; Joshua G Pierce; Valerian E Kagan; Peter Wipf; Anthony J Kanai; Joel S Greenberger
Journal:  In Vivo       Date:  2009 Sep-Oct       Impact factor: 2.155

7.  Design and synthesis of manganese porphyrins with tailored lipophilicity: investigation of redox properties and superoxide dismutase activity.

Authors:  Dorothée Lahaye; Kannan Muthukumaran; Chen-Hsiung Hung; Dorota Gryko; Júlio S Rebouças; Ivan Spasojević; Ines Batinić-Haberle; Jonathan S Lindsey
Journal:  Bioorg Med Chem       Date:  2007-08-19       Impact factor: 3.641

8.  Evaluation of the fullerene compound DF-1 as a radiation protector.

Authors:  Aaron P Brown; Eun Joo Chung; Mary Ellen Urick; William P Shield; Anastasia L Sowers; Angela Thetford; Uma T Shankavaram; James B Mitchell; Deborah E Citrin
Journal:  Radiat Oncol       Date:  2010-05-11       Impact factor: 3.481

9.  2-(1H-Indol-3-yl)-4,4,5,5-tetra-methyl-imidazolidine-1-oxyl 3-oxide.

Authors:  Hai-Bo Wang; Lin-Lin Jing; Ru Jiang; Peng Liu; Xiao-Li Sun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-01-23

10.  Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger.

Authors:  M Novelli; B Bonamassa; M Masini; N Funel; D Canistro; V De Tata; M Martano; A Soleti; D Campani; M Paolini; P Masiello
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.